Roche has purchased Stratos Group's DNA sequencing spinoff five years after its corporate venturing subsidiary contributed to a $30m series B round.
Stratos Genomics, a US-based DNA sequencing technology developer spun off by technology development services provider Stratos Group, has been acquired for an undisclosed amount by another shareholder, pharmaceutical firm Roche.
Spun off in 2007, Stratos Genomics has developed technology dubbed Sequencing by Expansion (SBX) which facilitates rapid and cost-efficient applications such as the diagnosis of infectious diseases and whole-genome sequencing.
SBX will be integrated into Roche’s nanopore sequencer, which is currently under development and which is expected to deliver end-to-end…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
